My approach to patients intolerant to statins

Trends Cardiovasc Med. 2015 Apr;25(3):265-6. doi: 10.1016/j.tcm.2014.09.015. Epub 2015 Jan 6.

Author

Seth S Martin¹

Affiliation

¹ Pollin Cardiovascular Prevention Fellow, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease; Marie-Josée and Henry R. Kravis Fellow, Division of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland. Electronic address: smart100@jhmi.edu.

PMID: 25802226
DOI: 10.1016/j.tcm.2014.09.015

No abstract available

MeSH terms

Atherosclerosis / prevention & control*
Cardiovascular Diseases / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Muscular Diseases / chemically induced

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors